3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
2
Phase 1
2
Phase NA
1
Phase 4
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Thyroid Neoplasms
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Neoplasm Metastasis
1
Carcinoma, Medullary
1
Interventions
vandetanib
1
cabozantinib
1
Lutetium-177
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Carcinoma, Medullary
×
cabozantinib
×
Clear all
NCT01896479
2025-09-02
EXAMINER
Exelixis
Phase 4
Active not recruiting
247 enrolled
14 charts